Neuroscience News and Research

RSS

UC Santa Barbara neuroscientists uncover mechanism of Alzheimer's progression

Medical research has yet to discover an Alzheimer's treatment that effectively slows the disease's progression, but neuroscientists at UC Santa Barbara may have uncovered a mechanism by which onset can be delayed by as much as 10 years.

2 Sep 2015

Amgen, Novartis collaborate for Alzheimer's disease and migraine programs

Amgen today announced a neuroscience collaboration with Novartis in the areas of Alzheimer's disease and migraine. The collaboration accelerates Amgen's potential entry into Alzheimer's disease by teaming up with Novartis on a differentiated and genetically validated Alzheimer's disease program directed at genetically predisposed individuals at risk of developing Alzheimer's disease.

2 Sep 2015

GSA, ASHG and Gruber Foundation announce recipients of 2016 Rosalind Franklin Young Investigator Award

The Genetics Society of America (GSA), the American Society for Human Genetics (ASHG) and The Gruber Foundation are pleased to announce Maria Barna, PhD, of Stanford University; and Carolyn McBride, PhD, of Princeton University, as the 2016 recipients of the Rosalind Franklin Young Investigator Award.

2 Sep 2015

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients with Atrial Fibrillation), their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation (NVAF).

1 Sep 2015

Repetitive transcranial magnetic stimulation can alleviate FOG, improve motor skills in PD patients

About 50% of patients with Parkinson's disease (PD) experience freezing of gait (FOG), an inability to move forward while walking. This can affect not only mobility but also balance. In a new study published in Restorative Neurology and Neuroscience, researchers report that repetitive transcranial magnetic stimulation (rTMS) can reduce FOG and improve other motor skills in PD patients.

1 Sep 2015

FDA approves MagVenture MagVita TMS Therapy system for treatment of Major Depressive Disorder

On July 31, 2015 the US Food and Drug Administration cleared the MagVita TMS Therapy system for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

28 Aug 2015

Cholinergic neurons in basal forebrain broadcast message throughout the cerebral cortex

When a large combat unit, widely dispersed in dense jungle, goes to battle, no single soldier knows precisely how his actions are affecting the unit's success or failure. But in modern armies, every soldier is connected via an audio link that can instantly receive broadcasts - reporting both positive and negative surprises - based on new intelligence. The real-time broadcasts enable dispersed troops to learn from these reports and can be critical since no solider has an overview of the entire unit's situation.

28 Aug 2015

Consumers willing to pay 30% more for Fair Trade products, study finds

Products labeled with a Fair Trade logo cause prospective buyers to dig deeper into their pockets. In an experiment conducted at the University of Bonn, participants were willing to pay on average 30 percent more for ethically produced goods, compared to their conventionally produced counterparts.

28 Aug 2015

New study may lead to effective treatment to prevent common chemotherapy side effects in cancer patients

Annually, hundreds of thousands of patients battling cancer undergo chemotherapy, which often results in poorly tolerated side effects such as nausea, vomiting, and loss of the desire to eat.

28 Aug 2015

Aphantasia: A condition that describes people born with diminished visual imagery ability

If counting sheep is an abstract concept, or you are unable to visualise the faces of loved ones, you could have aphantasia - a newly defined condition to describe people who are born without a "mind's eye".

28 Aug 2015

Experimental gene therapy may prevent neuronal degeneration in patients with Alzheimer's disease

Degenerating neurons in patients with Alzheimer's disease (AD) measurably responded to an experimental gene therapy in which nerve growth factor (NGF) was injected into their brains, report researchers at University of California, San Diego School of Medicine in the current issue of JAMA Neurology.

28 Aug 2015

Discovery could help in development of novel cancer-selective viral therapies

Every organism--from a seedling to a president--must protect its DNA at all costs, but precisely how a cell distinguishes between damage to its own DNA and the foreign DNA of an invading virus has remained a mystery.

27 Aug 2015

Dementia sufferers may begin to lose awareness of memory problems 2-3 years before onset

People who will develop dementia may begin to lose awareness of their memory problems two to three years before the actual onset of the disease, according to a new study published in the August 26, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

27 Aug 2015

Theresa Alenghat receives 2015 AGA-CCFA-Janssen Research Award in IBD Epigenetics Research

The American Gastroenterological Association, in partnership with the Crohn's & Colitis Foundation of America and Janssen Biotech, Inc., announced today that Theresa Alenghat, VMD, PhD, from Cincinnati Children's Hospital Medical Center, OH, was awarded with the 2015 AGA-CCFA-Janssen Research Award in Inflammatory Bowel Disease (IBD) Epigenetics Research.

27 Aug 2015

Study provides insight into how the ability to inhibit an action affects attention and memory

You're driving on a busy road and you intend to switch lanes when you suddenly realize that there's a car in your blind spot. You have to put a stop to your lane change -- and quickly. A new study by Duke University researchers suggests that this type of scenario makes a person less likely to remember what halted the action -- for example, the make and model of the car in the blind spot.

27 Aug 2015

Physical inactivity poses important clinical, public health and fiscal challenges for the U.S.

What do a prominent physiologist and two-time survivor of pancreatic cancer and a world-renowned researcher whose landmark discoveries on aspirin, drug therapies of proven benefit and therapeutic lifestyle changes that have saved more than 1.1 million lives have in common? They are both passionate about the importance of regular physical activity in reducing risks of dying from heart attacks and strokes, as well as developing diabetes, hypertension and colon cancer. And more importantly, enhancing mental health and fostering healthy muscles, bones and joints in all Americans from childhood to the elderly.

27 Aug 2015

Researchers find that 26% of senior oncology patients use complementary or alternative medicines

Alternative medicines are widely thought to be at least harmless and very often helpful for a wide range of discomforts and illnesses. However, although they're marketed as "natural," they often contain active ingredients that can react chemically and biologically with other therapies.

27 Aug 2015

Mental visual imagery training may improve AM/EFT functioning in RR-MS patients

Patients with relapsing-remitting multiple sclerosis (RR-MS), the most common form of the disease, often have deficits in two neuropsychological functions, autobiographical memory (AM) and episodic future thinking (EFT), which impact quality of life.

26 Aug 2015

Shire enters into agreement with Sanquin for CINRYZE

Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.

25 Aug 2015

BET inhibitors can cause molecular changes in neurons, lead to memory loss in mice

Cancer researchers are constantly in search of more-effective and less-toxic approaches to stopping the disease, and have recently launched clinical trials testing a new class of drugs called BET inhibitors. These therapies act on a group of proteins that help regulate the expression of many genes, some of which play a role in cancer.

25 Aug 2015

Neuroscience News and Research

UC Santa Barbara neuroscientists uncover mechanism of Alzheimer's progression

Amgen, Novartis collaborate for Alzheimer's disease and migraine programs

GSA, ASHG and Gruber Foundation announce recipients of 2016 Rosalind Franklin Young Investigator Award

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Repetitive transcranial magnetic stimulation can alleviate FOG, improve motor skills in PD patients

FDA approves MagVenture MagVita TMS Therapy system for treatment of Major Depressive Disorder

Cholinergic neurons in basal forebrain broadcast message throughout the cerebral cortex

Consumers willing to pay 30% more for Fair Trade products, study finds

New study may lead to effective treatment to prevent common chemotherapy side effects in cancer patients

Aphantasia: A condition that describes people born with diminished visual imagery ability

Experimental gene therapy may prevent neuronal degeneration in patients with Alzheimer's disease

Discovery could help in development of novel cancer-selective viral therapies

Dementia sufferers may begin to lose awareness of memory problems 2-3 years before onset

Theresa Alenghat receives 2015 AGA-CCFA-Janssen Research Award in IBD Epigenetics Research

Study provides insight into how the ability to inhibit an action affects attention and memory

Physical inactivity poses important clinical, public health and fiscal challenges for the U.S.

Researchers find that 26% of senior oncology patients use complementary or alternative medicines

Mental visual imagery training may improve AM/EFT functioning in RR-MS patients

Shire enters into agreement with Sanquin for CINRYZE

BET inhibitors can cause molecular changes in neurons, lead to memory loss in mice

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News